Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
26.94
-0.32 (-1.17%)
Oct 12, 2026, 12:17 PM EDT - Market open
Zenas BioPharma Employees
Zenas BioPharma had 167 employees as of December 31, 2025. The number of employees increased by 37 or 28.46% compared to the previous year. That makes Zenas BioPharma the 28,072nd largest employer in the world and 3,556th in the United States.
Employees
167
Change (1Y)
37
Growth (1Y)
28.46%
Revenue / Employee
$5,988
Profits / Employee
-$2,900,503
Market Cap
1.76B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 167 | 37 | 28.46% |
| Dec 31, 2024 | 130 | 23 | 21.50% |
| Sep 30, 2024 | 115 | 31 | 36.90% |
| Jun 30, 2024 | 114 | 30 | 35.71% |
| Mar 31, 2024 | 107 | - | - |
| Sep 30, 2023 | 84 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Intellia Therapeutics | 377 |
| Nuvation Bio | 305 |
| UroGen Pharma | 300 |
| Structure Therapeutics | 281 |
| Biohaven | 274 |
| Xencor | 260 |
| Zymeworks | 231 |
| Absci | 140 |
ZBIO News
- 5 hours ago - Zenas BioPharma presents new obexelimab data - TheFly
- 5 days ago - Zenas BioPharma Announces Upcoming Presentations of Orelabrutinib Data in Relapsing Remitting Multiple Sclerosis, Clinical Trial Designs in Progressive Multiple Sclerosis and Other Multiple Sclerosis Portfolio Data at MSToronto2026 - GlobeNewsWire
- 6 days ago - Zenas BioPharma to Host Virtual R&D Event - GlobeNewsWire
- 12 days ago - Zenas BioPharma price target raised to $48 from $41 at Citi - TheFly
- 13 days ago - Zenas BioPharma Transcript: Study update - Transcripts
- 13 days ago - Zenas BioPharma Slides: Study update - Filings
- 20 days ago - Zenas BioPharma announces new data from Phase 3 INDIGO trial on obexelimab - TheFly
- 20 days ago - Zenas BioPharma Announces Upcoming Presentations of Obexelimab Data in IgG4-Related Disease at the IgG4ward! 6th International Symposium on IgG4-Related Disease and ACR Convergence 2026 - GlobeNewsWire